Ikerbasque. Basque Foundation for Science

You are:
  1. Home
  2. Our Researchers

Calls
Ikerbasque
Science in Basque Country

Euskadi - Basque Country
European Commission


 

2015 Annual Report
2016 Science Report
Transparency
sciencecareers_eu


Mari Cruz Rodríguez-Oroz

Mari Cruz Rodríguez-Oroz

Ikerbasque Research Professor
(Spain)

  • Doctor in Medicine and Surgery from University La Laguna (Spain)
  • Previous research experience in different centers in Spain, UK and USA
  • Prize Instituto de neurociencias Federico Oloriz to the best young researcher of the year, Granada 2002.
  • Research line: Parkinson's disease, mainly focused on the surgical treatment and the associated cognitive and behavioural problems as well as the pathophysiology of basal ganglia in this disease
  • Comes from the Clinic Universidad de Navarra and CIMA

view curriculum
 download (383 KB.)

Publications

2016

Garcia-Garcia D, Guridi J, Toledo JB, Alegre M, Obeso JA, Rodríguez-Oroz MC. (2016)
Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.
Journal of Neurosurgery

Bergareche A, Rodríguez-Oroz MC, Estanga A, Gorostidi A, López de Munain A, Castillo-Triviño T, Ruiz-Martínez J, Mondragón E, Gaig C, Lomeña F, Sarasqueta C, Tolosa E, Martí-Massó JF. (2016)
DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2 R1441G Parkinson’s disease
Mov Disorders

Gasca-Salas C, Clavero P, García-García D, Obeso JA, Rodríguez-Oroz MC. (2016)
Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment.
Human Brain Mapping

Hamel W, Köppen JA, Alesch F, Antonini A, Barcia JA, Bergman H, Chabardes S, Contarino MF, Cornu P, Demmel W, Deuschl G, Fasano A, Kühn AA, Limousin P, McIntyre CC, Mehdorn HM, Pilleri M, Pollak P, Rodríguez-Oroz MC, Rumià J, Samuel M, Timmermann L, Valld (2016)
Targeting of the subthalamic nucleus for deep brain stimulation: a survey among Parkinson's disease specialists
World Neurosurgery

Garcia-Garcia D, Guridi J, Toledo JB, Alegre M, Obeso JA, Rodríguez-Oroz MC. (2016)
Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.
Journal of neurosurgery

Gorostidi A, Martí-Massó JF, Bergareche A, Rodríguez-Oroz MC, López de Munain A, Ruiz-Martínez J. (2016)
Genetic Mutation Analysis of Parkinson's Disease Patients Using Multigene Next-Generation Sequencing Panels.
Molecular Diagnosis & Therapy

Delgado-Alvarado M, Gago B, Navalpotro-Gomez I, Jiménez-Urbieta H, Rodriguez-Oroz MC. (2016)
Biomarkers for dementia and mild cognitive impairment in Parkinson's disease (review)
Movement Disorders

Santos-García D, Mir P, Cubo E, Vela L, Rodríguez-Oroz MC, Martí MJ, Arbelo JM, Infante J, Kulisevsky J, Martínez-Martín P; COPPADIS Study Group (2016)
Erratum to: COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's diseas
BMC Neurology

Santos-García D, Mir P, Cubo E, Vela L, Rodríguez-Oroz MC, Martí MJ, Arbelo JM, Infante J, Kulisevsky J, Martínez-Martín P; COPPADIS Study Group (2016)
COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progressio
BMC Neurology

Garcia-Esparcia P, Koneti A, Rodríguez-Oroz MC, Lago B, Del Rio J, Ferrer I (2016)
Mitochondrial activity in the frontal cortex area 8 and angular gyrus in Parkinson's disease and Parkinson's disease with dementia
Brain Pathology

2015

Delgado Alvarado M, de la Riva P, Jimenez H, Gago B, Gabilondo A, Bornstein B, Rodriguez-Oroz MC (2015)
Parkinsonism, cognitive deficit and behavioral disturbance caused by a novel mutation in the polymerase gamma gene
J Neurol Sci

Samuel M, Rodriguez-Oroz M, Antonini A, Brotchie JM, Ray Chaudhuri K, Brown RG, Galpern WR, Nirenberg MJ, Okun MS, Lang AE. (2015)
Management of impulse control disorders in Parkinson's disease: Controversies and future approaches.
Mov Disorders Journal

Marin C, Bonastre M, Mengod G, Cortés R, Rodríguez-Oroz MC (2015)
From unilateral to bilateral parkinsonism: Effects of lateralization on dyskinesias and associated molecular mechanisms.
Neuropharmacology

Rodriguez-Oroz MC, Gago B, Clavero P, Delgado-Alvarado M, Garcia-Garcia D, Jimenez-Urbieta H (2015)
The relationship between atrophy and hypometabolism: is it regionally dependent in dementias?
Curr Neurol Neurosci Rep

Bastide MF, Meissner WG, Picconi B, Fasano S, Fernagut PO, Feyder M, Francardo V, Alcacer C, Ding Y, Brambilla R, Fisone G, Jon Stoessl A, Bourdenx M, Engeln M, Navailles S, De Deurwaerdère P, Ko WK, Simola N, Morelli M, Groc L, Rodriguez MC, Gurevich EV, (2015)
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Prog Neurobiol

Jiménez-Urbieta H, Gago B, de la Riva P, Delgado-Alvarado M, Marin C, Rodriguez-Oroz MC (2015)
Dyskinesias and impulse control disorders in Parkinson's disease: From pathogenesis to potential therapeutic approaches
Neurosci Biobehav Rev.

Trenkwalder C, Chaudhuri KR, Martinez-Marin P, Rascol O, Ehret R, Vališ M, Sátori M, Krygowska-Wajs A, Marti MJ, Reimar K, Oksche A, Lomax M, DeCesare J, Hopp M, PANDA study group (2015)
Prolonged-release oxycodone–naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial
The Lancet Neurology

2014

Obeso I, Wilkinson L, Casabona E, Speekenbrink M, Bringas ML, Alvarez M, Alvarez L, Pavon N, Rodríguez-Oroz MC, Macías R , Obeso JA, Jahanshahi M (2014)
The subthalamic nucleus and inhibitory control: Impact of subthalamotomy in Parkinson’s disease
Brain

Geurtsen GJ, Hoogland J, Goldman JG, Schmand BA, Tröster AI, Burn DJ, Litvan I., on behalf of the MDS Study group on the validation of PD-MCI criteria (2014)
Parkinson's disease mild cognitive impairment: application and validation of the criteria
J Parkinsons Dis

Rafael González-Redondo, David García-García, Pedro Clavero, Carmen Gasca-Salas, Reyes García-Eulate, José L. Zubieta, Javier Arbizu, José A. Obeso, María C. Rodríguez-Oroz (2014)
Grey matter hypometabolism and atrophy in Parkinson’s disease with cognitive impairment: a two-step process
Brain

Obeso JA, Rodriguez-Oroz MC, Stamelou M, Bhatia KP, Burn DJ (2014)
The expanding universe of disorders of the basal ganglia
Lancet

Estanga A, Rodriguez-Oroz MC, Ruiz-Martinez J, Barandiaran M, Gorostidi A, Bergareche A, Mondragon E, Lopez de Munain A, Marti-Masso JF (2014)
Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2
Parkinsonism Relat Disord

Gasca-Salas C, Estanga A, Clavero P, Aguilar-Palacio I, Gonzalez Redondo R, Obeso JA, Rodríguez Oroz MC (2014)
Longitudinal Assessment of the Pattern of Cognitive Decline in Non-Demented Patients with Advanced Parkinson’s Disease
Journal of Parkinson’s Disease

2013

Alvarez-Erviti L, Seow Y, Schapira AH, Rodriguez-Oroz MC, Obeso JA, Cooper JM (2013)
Influence of microRNA deregulation on chaperone-mediated autophagy and ?-synuclein pathology in Parkinson's disease
Cell Death Dis

Gago B, Marin C, Rodríguez-Oroz MC, Obeso JA (2013)
L-Dopa-induced dyskinesias in unilateral 6-hydroxydopamine-lesioned rats are not modified by excitotoxic lesion of the entopeduncular nucleus and substantia nigra pars reticulata
Synapse

Obeso I, Wilkinson L, Rodríguez-Oroz MC, Obeso JA, Jahanshahi M (2013)
Bilateral stimulation of the subthalamic nucleus has differential effects on reactive and proactive inhibition and conflict-induced slowing in Parkinson's disease
Exp Brain Res

Ortega-Cubero S, Clavero P, Irurzun C, Gonzalez-Redondo R, Guridi J, Obeso JA, Rodriguez-Oroz MC (2013)
Effect of deep brain stimulation of the subthalamic nucleus on non-motor fluctuations in Parkinson's disease: Two-year' follow-up.
Parkinsonism Relat Disord

Rodriguez-Oroz MC, Obeso JA (2013)
Commentary
Mov Disord

Marin C, Bonastre M, Mengod G, Cortés R, Rodríguez-Oroz MC, Obeso JA (2013)
Subthalamic 6-OHDA-induced lesion attenuates levodopa-induced dyskinesias in the rat model of Parkinson's disease
Exp Neurol

Miquel M, Spampinato U, Latxague C, Aviles-Olmos I, Bader B, Bertram K, Bhatia K, Burbaud P, Burghaus L, Cho JW, Cuny E, Danek A, Foltynie T, Garcia Ruiz PJ, Giménez-Roldán S, Guehl D, Guridi J, Hariz M, Jarman P, Kefalopoulou ZM, Limousin P, Lipsman N, L (2013)
Short and long term outcome of bilateral pallidal stimulation in chorea-acanthocytosis
PLoS One

Ruiz-Martínez J, de la Riva P, Rodríguez-Oroz MC, Rezola EM, Bergareche A, Gorostidi A, Gago B, Estanga A, Larrañaga N, Sarasqueta C, de Munain AL, Massó JF (2013)
Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations in LRRK2
Mov Disord

Toledo JB, López-Azcárate J, Garcia-Garcia D, Guridi J, Valencia M, Artieda J, Obeso J, Alegre M, Rodriguez-Oroz MC (2013)
High beta activity in the subthalamic nucleus and freezing of gait in Parkinson's disease
Neurobiol Dis

2012

Rafael González-Redondo, Jon Toledo, Pedro Clavero, Isabel Lamet, David García-García, Reyes García-Eulate, Pablo Martínez-Lage, María C. Rodríguez-Oroz (2012)
The impact of silent vascular brain burden in cognitive impairment in Parkinson’s disease
Eur J Neurol

Litvan I, Emre M, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA (2012)
Diagnostic criteria for Mild Cognitive Impairment in Parkinson’s Disease (PD-MCI): Movement Disorder Society Task Force Guidelines
Mov Disord

Pelayo-Negro AL, Sánchez-Quintana C, Rodríguez-Oroz MC, Volpini V, Zeviani M, Tola-Arribas MA, Berciano J, Infante J (2012)
Screening for POLG W748S and A467T mutations in ataxia patients from Spain
Mov Disord

Lorenzo-Betancor O, Samaranch L, Ezquerra M, Tolosa E, Lorenzo E, Irigoyen J, Gaig C, Pastor MA, Soto-Ortolaza AI, Ross OA, Rodríguez-Oroz MC, Valldeoriola F, Martí MJ, Luquin MR, Perez-Tur J, Burguera JA, Obeso JA, Pastor P (2012)
LRRK2 haplotype-sharing analysis in Parkinson's disease reveals a novel p.S1761R mutation
Mov Disord

Blesa J, Pifl C, Sánchez-González MA, Juri C, García-Cabezas MA, Adánez R, Iglesias E, Collantes M, Peñuelas I, Sánchez-Hernández JJ, Rodríguez-Oroz MC, Avendaño C, Hornykiewicz O, Cavada C, Obeso JA (2012)
The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: A PET, histological and biochemical study
Neurobiol Dis.

Rodriguez-Oroz MC (2012)
Methylphenidate for freezing of gait in Parkinson's disease.
Lancet Neurol

Guridi J, Rodriguez-Oroz MC, Alegre M, Obeso JA (2012)
Hardware complications in deep brain stimulation: Electrode impedance and loss of clinical benefit
Parkinsonism Relat Disord

Alegre M, López-Azcárate J, Alonso-Frech F, Rodríguez-Oroz MC, Valencia M, Guridi J, Artieda J, Obeso JA (2012)
Subthalamic activity during diphasic dyskinesias in Parkinson's disease
Mov Disord

Garcia-Garcia D, Clavero P, Gasca Salas C, Lamet I, Arbizu J, Gonzalez-Redondo R, Obeso JA, Rodriguez-Oroz MC (2012)
Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease
Eur J Nucl Med Mol Imaging

Alegre M, Lopez-Azcarate J, Obeso I, Wilkinson L, Rodriguez-Oroz MC, Valencia M, Garcia-Garcia D, Guridi J, Artieda J, Jahanshahi M, Obeso JA (2012)
The subthalamic nucleus is involved in successful inhibition in the stop-signal task: A local field potential study in Parkinson's disease
Exp Neurol

Rodriguez-Oroz MC, Moro E, Krack P (2012)
Long-term outcomes of surgical therapies for Parkinson's disease
Mov Disord

Pagonabarraga J, Rodriguez-Oroz MC (2012)
Rasagiline in monotherapy in patients with early stages of Parkinson's disease and in combined and adjunct therapy to levodopa with moderate and advanced stages
Rev Neurol

Gorostidi A, Bergareche A, Ruiz-Martínez J, Martí-Massó JF, Rodriguez-Oroz MC, Varghese S, Qureshi MM, Alzahmi F, Al-Hayani A, de Munáin AL (2012)
Alpha-Synuclein Levels in Blood Plasma from LRRK2 Mutation Carriers
PLoS One

2011

Rodriguez-Oroz MC, López-Azcárate J, García-García D, Alegre M, Toledo J, Valencia M, Guridi J, Artieda J, Obeso JA (2011)
Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson’s disease
Brain

Litvan I, Aarsland D, Adler CH, Goldman JG, Kulisevsky J, Mollenhauer B, Rodriguez-Oroz MC, Tröster AI, Weintraub D (2011)
MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD-MCI
Mov Disord

Obeso I, Wilkinson L, Casabona E, Bringas ML, Alvarez M, Alvarez L, Pavón N, Rodríguez-Oroz MC, Macías R, Obeso JA, Jahanshahi M (2011)
Deficits in inhibitory control and conflict resolution on cognitive and motor tasks in Parkinson's disease
Exp Brain Res

Lorenzo-Betancor O, Samaranch L, García-Martín E, Cervantes S, Agúndez JA, Jiménez-Jiménez FJ, Alonso-Navarro H, Luengo A, Coria F, Lorenzo E, Irigoyen J, Pastor P; Iberian Parkinson's Disease Genetics Study Group Researchers (2011)
LINGO1 gene analysis in Parkinson's disease phenotypes
Mov Disord

García-Eulate R, García-García D, Dominguez PD, Noguera JJ, De Luis E, Rodriguez-Oroz MC, Zubieta JL (2011)
Functional bold MRI: advantages of the 3 T vs. the 1.5 T
Clin Imaging

Maria Cruz Rodriguez-Oroz, Concepcio´n Marin, Oriol de Fàbregues (2011)
Continuous Dopaminergic Stimulation Clinical Aspects and Experimental Bases
The Neurologist

Lorenzo-Betancor O, Samaranch L, Ezquerra M, Tolosa E, Lorenzo E, Irigoyen J, Gaig C, Pastor MA, Soto-Ortolaza AI, Ross OA, Rodríguez-Oroz MC, Valldeoriola F, Martí MJ, Luquin MR, Perez-Tur J, Burguera JA, Obeso JA, Pastor P (2011)
LRRK2 haplotype-sharing analysis in Parkinson's disease reveals a novel p.S1761R mutation
Mov disord

Litvan I, Emre M, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA (2011)
Diagnostic criteria for Mild Cognitive Impairment in Parkinson’s Disease (PD-MCI): Movement Disorder Society Task Force Guidelines
Mov disord

Books and book chapters

Published

  • Bastide MF, Meissner WG, Picconi B, Fasano S, Fernagut PO, Feyder M, Francardo V, Alcacer C, Ding Y, Brambilla R, Fisone G, Jon Stoessl A, Bourdenx M, Engeln M, Navailles S, De Deurwaerdère P, Ko WK, Simola N, Morelli M, Groc L, Rodriguez MC, Gurevich (2015)
    Type: chapters
    Book: Progress in Neurobiology
    Chapter: Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
    Page numbers: 96-168
    ISBN: 0555-4047 | England | Editors:
  • Jorge Guridi, Maria Cruz Rodriguez Oroz (2011)
    Type: chapters
    Book: Temblor
    Chapter: Tratamiento quirúrgico del temblor
    Page numbers: 175-199
    ISBN: 978-84-15340-18-8 | Barcelona | Editors: Alexander Gironel

Doctoral dissertations

  • Longitudinal study of cognitive impairment in Parkinson's disease
    2012 - 2016
    University of Navarra
    Carmen Gasca-Salas
  • Longitudinal study of cognitive impairment in Parkinson's disease
    2012 - 2016
    University of Navarra
    Carmen Gasca-Salas
  • Clinical and electrophysiological correlate of oscillatory activity in the subthalamic nucleus in Parkinson's disease
    2015 - 2015
    Universidad de Navarra
    Jon Toledo Atucha
  • Cognitive impairment associated with the R1441G mutation in LRRK2 gene: Neuropsychological Study in Parkinson Patients and Asymptomatic Carriers
    2015 - 2015
    Universidad del País Vasco (UPV/EHU)
    Ainara Estanga Alustiza
  • Longitudinal study of cognitive impairment in Parkinson's disease
    2012 - 2015
    University of Navarra
    Carmen Gasca-Salas
  • Longitudinal study of cognitive impairment in Parkinson's disease
    2012 - 2015
    University of Navarra
    Carmen Gasca-Salas
  • Longitudinal study of cognitive impairment in Parkinson's disease
    2015 - 2015
    University of Navarra
    Carmen Gasca-Salas
  • Correlación clínico topográfica del núcleo subtalámico en la enfermedad de Parkinson
    2008 - 2013

    David García García

Courses given

  • 2016
    Anatomy of the movement I. From the pyramidal pathway to the muscle. "Master of Neuropsychology" organized by the Universidad Autónoma de Barcelona (UAB). San Sebastian, 10th Octuber 2013.
  • 2014
    Fisiopatologia de los ganglios basales en el Máster "DIAGNOSTICO Y TRATAMIENTO DE LAS ENFERMEDADES NEURODEGENERATIVAS". Universidad del País Vasco UPV-EHU. 20 de Marzo de 2014

Managerial activities

  • Head of Neurodegenerative Diseases Research. Biodonostia Research Institute
  • Directora del grupo de enfermedades neurodegenerativas del Instituto Biodonostia.

Congresses, Proceedings & Scientific meetings

  • Discinesias orobucales y alteración de la marcha. . Navalpotro I, Rodríguez Oroz MC.
    VXIª REunión anual de vídeos grupo de estudio de trastornos del movimiento (G.E.T.M.) (2016) Congress
    Sociedad Española de Neurología (SEN) / Zaragoza (Talk)
  • Mioclonus velopalatino. . Navalpotro I, Rodríguez Oroz MC
    VXIª REunión anual de vídeos grupo de estudio de trastornos del movimiento (G.E.T.M.) (2016) Congress
    Sociedad Española de Neurología (SEN) / Zaragoza (Talk)
  • Cytokines in CSF and plasma as potential biomarkers for PD cognitive impairment. (Special mention “Study group abstracts” (35 were given out of 2111 total amount of abstracts)). Delgado-Alvarado M, Gago B, Gorostidi A, Jiménez-Urbieta H, Ruiz-Martínez A, Bergaretxe-Yarza A, Martí-Massó JF, Martínez-Lage P, Izagirre A, Oregi A, Sepúlveda L, Rodríguez-Oroz MC
    20th International congress of Parkinson’s disease and movement disorders (2016) Congress
    Berlin (Poster)
  • Cerebrospinal fluid biomarkers in Parkinson’s disease and associated cognitive impairment. Special mention "Study group abstracts” (35 were given out of 2111 total amount of abstracts). Delgado-Alvarado M., Gago B., Gorostidi A., Jiménez-Urbieta H., Ruiz-Martínez A., Bergaretxe-Yarza A., Martí-Massó JF., Martínez-Lage P., Izagirre A., Oregi A., Sepúlveda L., Rodríguez-Oroz MC
    20th International congress of Parkinson’s disease and movement disorders (2016) Congress
    Berlin (Poster)
  • A model of increased impulsivity in rats with bilateral parkinsonism treated with Pramipexole. Gago B., Jiménez-Urbieta H., Marín C., Delgado-Alvarado M., Rodríguez-Oroz MC
    10th Forum of European Neuroscience (FENS) (2016) Congress
    Copenhagen, Denmark (Poster)
  • Chronic pramipexole treatment increases impulsive choice in an ?-synuclein progressive parkinsonian model. A. Quiroga-Varela, H. Jimenez-Urbieta, I. Navalpotro, L. Merino, T. Rodríguez, M. Delgado-Alvarado, C. Marin, A. Oregi, B.Gago, M.C. Rodríguez-Oroz
    IV Congreso Internacional de Investigación e Innovación en Enfermedades Neurodegenerativas CIIIEN (2016) Congress
    Alicante (Poster)
  • 134. Hipometabolismo y atrofia cerebral en la progresión del deterioro cognitivo de la enfermedad de Parkinson. Rodríguez Oroz MC
    VIII Simposium Trastornos Cognitivos en la Enfermedad de Parkinson (2016) Congress
    San Sebastián, Spain (Talk)
  • The best articles of 2015-2016. . Rodríguez Oroz MC
    Advances in neurosciences. XV Controversias en Neurología (2016) Congress
    Madrid (Invited talk)
  • Visual hallucinations in Parkinson´s disease with mild cognitive impairment do not imply a more severe cognitive deficit but a more severe cerebral hypometabolism. C. Gasca-Salas, P. Clavero, D. García-García, R. González-Redondo, J. Obeso, M.C. Rodríguez-Oroz
    19th International Congress of Parkinson’s disease and movement disorders. San Diego, CA, USA, 14-18 June 2015. (2015) Congress
    Movement Disorders Society/San Diego, CA, USA (Poster)
  • Gray matter changes in Parkinson’s disease with freezing of gate. Delgado-Alvarado, L. García-Penton, H. Jiménez-Urbieta, B. Gago, C. Caballero, M. Carreiras, M.C. Rodriguez-Oroz
    19th International Congress of Parkinson’s disease and movement disorders. San Diego, CA, USA. (2015) Congress
    Movement Disorders Society/ San Diego, CA, USA. (Poster)
  • F-DOPA PET reveals a rostro-ventral striatal dopaminergic. A. Mari, M.C. Rodriguez Oroz, C. Juri, R. Gonzalez-Redondo, J. Arbizu, E. Prieto, J.A. Obeso
    19th International Congress of Parkinson’s disease and movement disorders. San Diego, CA, USA (2015) Congress
    Movement Disorders Society/San Diego, CA, USA (Poster)
  • Incidence and severity of impulse control disorders in Parkinson’s disease patients treated with dopamine agonists. M.C. Rodríguez-Oroz, R. Ribacoba Montero, A. Rojo-Sebastián, A. Sesar Ignacio, M. Delgado-Alvarado, B. Ares Pensado
    19th International Congress of Parkinson’s disease and movement disorders. San Diego, CA, USA (2015) Congress
    Movement Disorders Society/San Diego, CA, USA (Poster)
  • Language-mediated eye movements in Parkinson’s disease. Delgado-Alvarado, J.A. Duñabeitia, H. Jimenez-Urbieta, B. Gago, C. Caballero, M. Carreiras, M.C. Rodriguez-Oroz
    19th International Congress of Parkinson’s disease and movement disorders. San Diego, CA, USA (2015) Congress
    Movement Disorders Society/San Diego, CA, USA (Poster)
  • COPPADIS-2015 (COhort of Patient´s with PArkinson´s DIsease in Spain, 2015): A global Parkinson´s disease project underway. D. Santos García, T. de Deus Fonticoba, P. Mir, E. Cubo, L. Vela, M.C. Rodríguez-Oroz, J.M. Arbelo
    19th International Congress of Parkinson’s disease and movement disorders. San Diego, CA, USA (2015) Congress
    Movement Disorders Society/San Diego, CA, USA (Poster)
  • A model of increased impulsivity in rats with bilateral parkinsonism treated with Pramipexole. . Jiménez Urbieta H, Gabo B, Marin C, Delgado Alvarado M, Rodríguez Oroz MC.
    III International Congress on Research and Innovation in Neurodegenerative Diseases. 9th CIBERNED Scientific Forum (2015) Congress
    CIBERNED, Málaga (Poster)
  • Apomorphine-induced dyskinesias in parkinsonian rats: pet and histological studies. Gago B, García García De, Marin C, Jiménez Urbieta H, Oregui A, Gómez Vallejo V, Llop J, Mengod G, Cortés R, Delgado Alvarado M, Rodríguez Oroz MC
    III International Congress on Research and Innovation in Neurodegenerative Diseases. 9th CIBERNED Scientific Forum (2015) Congress
    CIBERNED, Málaga (Poster)
  • A model of increased impulsivity in rats with bilateral parkinsonism treated with Pramipexole. Jiménez Urbieta H, Gabo B, Marin C, Delgado Alvarado M, Rodríguez Oroz MC
    16 National Congress of the Spanish Society of Neuroscience (SENC) (2015) Congress
    Sociedad Española de Neurociencias (SENC) /Granada (Poster)
  • Apomorphine-induced dyskinesias in parkinsonian rats: pet and histological studies. Gago B, García García De, Marin C, Jiménez Urbieta H, Oregui A, Gómez Vallejo V, Llop J, Mengod G, Cortés R, Delgado Alvarado M, Rodríguez Oroz MC.
    16 National Congress of the Spanish Society of Neuroscience (SENC). Granada (2015) Congress
    Sociedad Española de Neurociencias (SENC)/Granada (Poster)
  • Language-mediated eye movements in Parkinson’s Disease. Delgado Alvarado M, Duñabeitia JA, Caballero C, García Pentón L, Ruiz Martínez J, Bergareche A, Marti Masso JF, Carreiras M, Rodriguez Oroz MC
    16 National Congress of the Spanish Society of Neuroscience (SENC) (2015) Congress
    Sociedad Española de Neurociencias (SENC)/Granada (Poster)
  • Gray matter changes in Parkinson’s Disease with freezing of gate. Delgado Alvarado M, García Pentón L, Jimenez Urbieta H, Gago B, Ruiz Martinez J, Bergareche A, Marti Masso JF, Caballero C, Carreiras M, Rodriguez Oroz MC
    16 National Congress of the Spanish Society of Neuroscience (SENC) (2015) Congress
    Sociedad Española de Neurociencias (SENC)/ Granada (Poster)
  • Administración dopaminergica continua. Evidencias vs experiencias. Rodríguez Oroz MC
    4ª Summit Latinoamericano de Neurociencias. (2015) Congress
    Summit Latinoamericano de Neurociencias/ Sao Paulo, Brasil (Invited talk)
  • Casos clínicos, Concurso Latinoamericano en la Enfermedad de Parkinson “Desafiando al experto”. . Rodríguez Oroz MC
    4ª Summit Latinoamericano de Neurociencias. (2015) Congress
    Summit Latinoamericano de Neurociencias/ Sao Paulo, Brasil (Invited talk)
  • Manifestaciones cognitivas en la Enfermedad de Parkinson. Rodríguez Oroz MC
    2º Simposio Parkinson Universidad Católica de Chile “Alteraciones Cognitivas y Conductuales en Enfermedad de Parkinson”. (2015) Congress
    Universidad Catolica de Chile/ Santiago de Chile (Invited talk)
  • Trastorno de control de impulsos en la Enfermedad de Parkinson. Rodriguez Oroz MC
    2º Simposio Parkinson Universidad Católica de Chile “Alteraciones Cognitivas y Conductuales en Enfermedad de Parkinson”. Santiago de Chile (2015) Congress
    Universidad Catolica de Chile/ Santiago de Chile (Invited talk)
  • Parkinson’s disease in advances stages. Rodríguez Oroz MC
    III International Congress on Research and Innovation in Neurodegenerative Diseases. 9th CIBERNED Scientific Forum (2015) Congress
    CIBERNED, Málaga (Invited talk)
  • Marcadores de imagen en el diagnóstico del MCI y la demencia en la EP. Rodríguez Oroz MC
    VIII Reunión nacional de trastornos del movimiento (2015) Congress
    Sociedad Españala de Trastornos del Movimiento/ Oviedo (Invited talk)
  • Neurobiología del sistema dopaminérgico normal y patológico. Rodríguez Oroz MC
    2º Desafío EPA (2015) Congress
    Madrid (Invited talk)
  • Cambios en sustancia gris en pacientes con enfermedad de Parkinson y bloqueos de la marcha. Delgado Alvarado Manuel, García Penton Lorna, Jimenez Urbieta Haritz, Gago Calderón Belén, Ruiz Martinez Javier, Bergareche Yarza Alberto, Martí Masso José Felix, Caballero Cesar, Carreiras Manuel, Rodriguez Oroz María Cruz.
    LXVII Reunión Anual de la Sociedad Española de Neurología. (2015) Congress
    Sociedad Española Neurologia/ Valencia (Poster)
  • Parkinson's disease from a translational perspective. Rodríguez Oroz MC
    Jornada Bioforo (2015) Congress
    Bioscience by Ikerbasque Researchers Bilbao UPV (Invited talk)
  • Management of Impulse control disorders in Pakinson's disease. Rodríguez Oroz MC
    XXI World Congress on Parkinson’s Disease and Related Disorders (2015) Congress
    Parkinson’s Disease and Related Disorders Society/ Milan (Invited talk)
  • Proyecto COPPADIS-2015:Cohort of Patients with PArkinson´s DIsease in Spain, 2015. Santos García Diego, de Deus Fonticoba Teresa, Mir Rivera Pablo, Cubo Delgado Esther, Vela Desojo Lydia, Rodríguez Oroz Maria Cruz, Arbelo González Jose Matías, de Fábregues-Boixar Nebot Oriol, Hernández Vara Jorge, Borrué Fernández Carmen, Martí Domenec
    LXVII Reunión Anual de la Sociedad Española de Neurología (2015) Congress
    Sociedad Española Neurologia/ Valencia (Poster)
  • Manifestaciones clínicas, hallazgos de neuroimagen y perfil neuropsicológico en la neuroacantocitosis. Descripción de tres casos. Minguez Olaondo Ane, Imaz Aguayo Laura, Trzeciak Malwina, Echeveste Gonzalez Beatriz Eugenia, Moreno Ajona David, Rodríguez Oroz Maricruz, Luquin Piudo Rosario, Carmona Abellán Maria del Mar
    LXVII Reunión Anual de la Sociedad Española de Neurología (2015) Congress
    Sociedad Española Neurologia/ Valencia (Poster)
  • Language-mediated eye movements in Parkinson's Disease. . Delgado Alvarado, Manuel, Duñabeitia Jon Andoni, Caballero Cesar, García Penton Lorna, Ruiz Martinez Javier, Bergareche Yarza Alberto, Martí Masso José Felix, Carreiras Manuel, Rodriguez Oroz María Cruz
    LXVII Reunión Anual de la Sociedad Española de Neurología (2015) Congress
    Sociedad Española Neurologia/ Valencia (Poster)
  • Principios farmacologicos e implicaciones clínicas de la administración dopaminérgica continua con foco en rotigotina. Rodriguez-Oroz Maria Cruz
    4ª Summit Latinoamericano de Neurociencias. (2015) Congress
    Summit Latinoamericano de Neurociencias/ Sao Paulo, Brasil (Talk)
  • Codirectora de 2nd Basque Neuroscience Meeting – Neurogune. Rodríguez Oroz MC
    2nd Basque Neuroscience Meeting – Neurogune (2014) Congress
    San Sebastián (Organization and management)
  • Early PD treatment and long-term benefits. . Rodríguez Oroz MC
    Early PD treatment and long-term benefits. The European Rotigotine Experience Workshops 2014 (EU-REW). (2014) Congress
    Munich, Alemania (Talk)
  • Evaluation of MCI and Dementia in patients with PD using PET. Rodríguez Oroz MC
    3rd European Conference on Clinical Neuroimaging (2014) Congress
    Lille, France (Talk)
  • La enfermedad de Parkinson – Avances y retos en investigación clínica y traslacional. Rodriguez Oroz MC
    Fundación Real Academia Nacional de Medicina (2014) Congress
    Fundación Real Academia Nacional de Medicina (Talk)
  • Clinical relevance of basal ganglia pathways. Rodríguez Oroz MC
    18th International Congress of Parkinson’s Disease and Movement Disorders (2014) Congress
    Stockholm, Sweden (Talk)
  • ESPECTRO CLÍNICO Y FISIOPATOLOGÍA. Rodríguez Oroz MC
    FORUM - IV ENCUENTRO CIENTÍFICO (2014) Congress
    Madrid (Talk)
  • VII Simposio sobre Deterioro Cognitivo en la enfermedad de Parkinson. Rodríguez Oroz
    VII Simposio sobre Deterioro Cognitivo en la enfermedad de Parkinson (2014) Congress
    San Sebastian (Organization and management)
  • Dopamine D4 receptor counteracts morphine-induced changes in µ opioid receptor signaling in the striosomes of the rat Caudate Putamen. Gago B, Suárez D, Valderrama A, Roales R, Van Craenenbroeck K, Duchou J, Borroto DO, Medina J, de la Calle A, Fuxe K, Rodriguez Oroz MC, Rivera A
    Neurogune - 2nd BASQUE NEUROSCIENCE MEETING (2014) Congress
    San Sebastian (Poster)
  • R1441G mutation in Parkinson ’s disease. What we know 10 years after. Ruiz Martínez J, Mondragón REzola E, Bergareche Yarza A, Gorostidi Pagola A, Estanga Alustiza A, Rodríguez Oroz MC, de la Riva Juez P, Gago Calderón B, López de Munain Arregui A, Paisán Ruiz C, Martí Massó JF
    LXVI Reunión anual de la Sociedad Española de Neurología (2014) Congress
    Valencia (Poster)
  • Parkinsonism, progressive external ophthalmoplegia, ptosis and behavioral disturbances by POLG novel gene mutation. Delgado Alvarado M, de la Riva Juez P, Rodríguez Oroz MC
    LXVI Reunión anual de la Sociedad Española de Neurología (2014) Congress
    Valencia (Poster)
  • Dopamine D4 receptor counteracts morphine-induced changes in µ opioid receptor signaling in the striosomes of the rat caudate putamen. B. Gago, D. Suarez-Boomgaard, A. Valderrama, R. Roales-Buján, K. Van Craenenbroeck, J. Duchou, D. O. Borroto-Escuela, J. Medina-Luque, M. C. Rodriguez-Oroz, A. de la Calle, K. Fuxe, A. Rivera
    Society for Neuroscience 2014 (2014) Congress
    Washington DC (Poster)
  • Deep brain stimulation experience: Globus Pallidus pars interna versus subthalamic nucleus. Maria Cruz Rodríguez Oroz
    4ta conferencia científica internacional restauración neurológica (2014) Congress
    La Habana, Cuba (Talk)
  • Clinical relevance of basal ganglia pathways. Maria Cruz Rodríguez Oroz
    18th International Congress of Parkinson’s Disease and Movement Disorders (2014) Congress
    Stockholm, Sweden (Talk)
  • The pressing need: new biomarkers in neurodegenerative diseases. Maria Cruz Rodríguez Oroz
    Summer School. From bed to bench and back (2014) Congress
    Pamplona (Talk)
  • Manifestaciones clínicas en las fases avanzadas de la EP y sus bases fisiopatológicas. Maria Cruz Rodríguez Oroz
    VII Simposium trastornos cognitivos en la enfermedad de parkinson (2014) Congress
    San Sebastián (Talk)
  • Estimulación cerebral profunda en coreas hereditarios. García J, López-Sendón JL, Muñoz , J.Esteban, Lezcano E, Rodríguez-Oroz MC; Bilbao G, Valldeoriola F, Gómez JC, Infante J, Rumià J, Ayerbe J, García de Yébenes J, García-Ruiz PJ
    LXV Reunión Anual Sociedad Española Neurología (2013) Congress
    Barcerlona (Talk)
  • Apomorphine-induced dyskinesias in unilateral 6-hydroxydopamine-lesioned rats: quetiapine dose-response effects. Gago B, Marin C, García-García D, Jiménez-Urbieta H, Oregui A, Gómez-Vallejo V, Llop J, Rodriguez-Oroz MC
    XV Congress of Spanish Society of Neuroscience (SENC) (2013) Congress
    Oviedo (Poster)
  • Apomorphine-induced abnormal involuntary movements in unilateral 6-hydroxydopamine-lesioned rats: Quetiapine effects. Gago B, Marin C, García-García D, Jiménez-Urbieta H, Oregui A, Gómez-Vallejo V, Llop J, Rodríguez-Oroz MC
    NEUROGUNE 2013 Basque Neuroscience Meeting (2013) Congress
    Bilbao (Poster)
  • Diagnóstico integral de la Enfermedad de Parkinson. Rodriguez Oroz MC
    Summit Latinoamericano de Neurociencias (2013) Congress
    Ciudad de Méjico (Talk)
  • ¿Nos interesa lo mismo a los médicos y a los pacientes sobre enfermedad de Parkinson? . Rodriguez Oroz MC
    Summit Latinoamericano de Neurociencias (2013) Congress
    Ciudad de Méjico (Talk)
  • ¿Por qué no se ha resuelto aún la enfermedad de Huntington?. . Rodriguez Oroz MC
    III Forum UCB en trastornos del movimiento (2013) Congress
    Madrid (Talk)
  • Psychiatric comorbidities ICD. Pros and Cons. Rodríguez Oroz MC
    International DBS Masters Debate. Changing the DBS Paradigm (2013) Congress
    France (Talk)
  • VI Simposio sobre Deterioro Cognitivo en la enfermedad de Parkinson. Rodríguez Oroz
    VI Simposio sobre Deterioro Cognitivo en la enfermedad de Parkinson (2013) Congress
    San Sebastian (Organization and management)
  • Avances en el conocimiento de la enfermedad de Parkinson. Rodriguez Oroz
    Cursos de verano de la Univesidad del Pais Vasco (2013) Congress
    Palacio Miramar. San Sebastian (Organization and management)
  • Disquinesias en el modelo animal de enfermedad de Parkinson de la rata lesionada unilateralmente con 6-OHDA: efecto de la quetiapina. Gago B, Marin C, Garcia-Garcia D, Jimenez-Urbieta H, Gomez-Vallejo V, Llop J, Rodriguez-Oroz MC
    XXXIII Annual Meeting of Spanish Research Group on neurotransmission and neuroprotection (GENN). (2012) Congress
    Oñate (Talk)
  • Longitudinal study of silent vascular burden and cognition in Parkinson’s disease. R. Gonzalez-Redondo, J. Toledo, P. Clavero, D. Garcia-Garcia, I. Lamet, P. Martinez-Lage, J.A. Obeso, M.C. Rodriguez-Oroz
    15th Internacional crogress of Parkinson’s disease and movement disorders (2011) Congress
    Toronto. Canada (Poster)
  • Comparison between grey matter hypometabolism and atrophy in dementia and mild cognitive impairment in Pakinson’s disease. D. Garcia-Garcia, P. Clavero, R. Gonzalez-Redondo, R. Garcia de Eulate, I. Lamet, J. Arbizu, J.A. Obeso, M.C. Rodriguez-Oroz
    15th Internacional crogress of Parkinson’s disease and movement disorders (2011) Congress
    Toronto. Canada (Poster)
  • Subthalamic activity during a motor inhibition task. M. Alegre, I. Obeso, J. Lopez-Azcarate, M.C. Rodriguez-Oroz, L. Wilkinson, J. Guridi, M. Valencia, J. Artieda, M. Jahanshahi
    15th Internacional crogress of Parkinson’s disease and movement disorders (2011) Congress
    Toronto. Canada (Poster)
  • Subthalamic activity during a motor inhibition task. M. Alegre, I. Obeso, J. Lopez-Azcarate, M.C. Rodriguez-Oroz, L. Wilkinson, J. Guridi, M. Valencia, J. Artieda, M. Jahanshahi
    15th Internacional crogress of Parkinson’s disease and movement disorders (2011) Congress
    Toronto. Canada (Poster)
  • Relationship between subthalamic nucleus oscillatory activity and age, gender, and clinical features in Parkinson’s disease. J. Toledo, M. Alegre, J. López-Azcarate, J. Guridi, J. Iriarte, J. Obeso, J. Artieda, M.C. Rodriguez-Oroz
    15th Internacional crogress of Parkinson’s disease and movement disorders (2011) Congress
    Toronto. Canada (Poster)
  • Efecto de la lesión combinada del núcleo entopeduncular y de la sustancia negra reticulata en las disquinesias inducidas por levodopa en ratas lesionadas unilateralmente con 6-OHDA. Gago B, Marin C, Rodríguez-Oroz MC, Obeso JA
    XIII Congreso de la Sociedad Española de Neurociencias (2011) Congress
    Salamanca (Poster)
  • Quinolinic acid lesion in entopeduncular nucleus and substantia nigra: effects on levodopa-induced dyskinesias in unilateral 6-hydroxydopamine lesioned rats. Gago B, Rodríguez-Oroz MC, Marin C, Obeso JA
    41st Annual Meeting Neuroscience (2011) Congress
    Washington DC (EEUU) (Poster)
  • Effect of unilateral subthalamotomy in Parkinson’s disease on response inhibition. J. Obeso, I. Obeso, L. Wilkinson, E. Casabona, M. Bringas, M.Alvarez, L Alvarez, N. Pavon, M.Rodriguez-Oroz. R, Macias, M. Jahanshah JA
    41st Annual Meeting Neuroscience. Washington DC (EEUU) (2011) Congress
    Washington DC (EEUU) (Poster)
  • Basal ganglia compensatory mechanisms of dopaminergic deficit: Early changes in the MPTP monkey model. R. Adanez, C. Marin, G Mengod, R. Cortes, E. Iglesias, J. Blesa, M.C.Rodriguez-oroz, J.A. Obeso JA
    41st Annual Meeting Neuroscience (2011) Congress
    Washington DC (EEUU) (Poster)
  • Diferencias clínicas entre las mutaciones G2019S y R1441G en pacientes con enfermedad de Parkinson. Ruiz-Martínez J, Gorostidi A, Bergareche A, Estanga A, Sarasqueta C, Rodriguez-Oroz MC, Martí Massó JF
    LXIII Reunión Anual de la Sociedad Española de Neurología (2011) Congress
    Barcelona (Poster)
  • Eficacia de la estimulación cerebral profunda del núcleo subtalámico en las fluctuaciones no motoras en la. Ortega Cubero, S; Irurzun Baron, C.Clavero Ibarra, P; González Redondo, R; Obeso Inchausti, JA.;Rodriguez Oroz, M.C
    LXIII Reunión Anual Sociedad española de Neurología (2011) Congress
    Bacelona (Poster)
  • El impacto de las lesiones vasculares silentes en el deterioro cognitivo de la enfermedad de Parkinson. González Redondo, R.; Toledo Atucha, J; Clavero Ibarra, P.;
    LXIII Reunión Anual Sociedad española de Neurología (2011) Congress
    Barcelona (Poster)
  • Caracterización del deterioro cognitivo en la enfermedad de Parkinson: comparación entre el hipometabolismo y la atrofia de la corteza cerebral. García García, D; Gonzalez Redondo, R; Clavero Ibarra, P
    LXIII Reunión Anual Sociedad española de Neurología (2011) Congress
    Barcelona (Poster)
  • Actividad en el núcleo subtalámico durante disquinesias bifásicas en pacientes con enfermedad de Parkinson. M. Alegre Esteban, J. López Azcárate, M. Valencia Ustárroz,
    LXIII Reunión Anual Sociedad española de Neurología (2011) Congress
    Barcelona (Poster)
  • Asociación de la imantación de la marcha y la función cognitiva con el pico beta alto en el núcleo subtalámico. J.B. Toledo Atucha, M. Alegre, J. López Azcarate, J. Guridi, J. Iriarte, J. Obeso, J. Artieda y M.C. Rodríguez-Oroz
    LXIII Reunión Anual Sociedad española de Neurología (2011) Congress
    Barcelona (Poster)
  • 87. Futuro de la terapéutica de la enfermedad de Parkinson: ¿ algo nuevo a corto plazo?.. M. Cruz Rodriguez Oroz
    Controversias en la enfermedad de Parkinson y otros trastornos del moviemiento (2011) Congress
    San Sebastian (Talk)
  • 88. Reconocimiento y tratamiento de los trastornos de control de impulsos en la enfermedad de Parkinsono. M. Cruz Rodriguez Oroz
    XIII Controversias en Neurologia. Retos en la enfermedad de Parkinson y trastornos del movimiento (2011) Congress
    Madrid (Talk)
  • Trastornos del movimiento y ataxia espinocerebelosa. M. Cruz Rodriguez Oroz
    1er simposium de Ataxias espinocerebelosas y enfermedad de Parkinson. Etiopatogenia y posibilidades terapéuticas (2011) Congress
    Holguin, Cuba (Talk)
  • 93. The anatomical source of the signs and symptoms of Parkinson’s disease. M. Cruz Rodriguez Oroz
    15th International Congress of Parkinsons’s disease and Movement Disorders (2011) Congress
    Toronto, Canada (Talk)
  • Clinical Case in Parkinson's disease surgery. M. Cruz Rodriguez Oroz
    Movemente disorders and DBS. Time for update and upgrade. International Symposium (2011) Congress
    Toronto Western Hospital (Talk)
  • 96. Circuitos y actividad oscilatoria: disquinesias e impulsividad en la enfermedad de Parkinson. M. Cruz Rodriguez Oroz
    XIV Congreso Nacional de la Sociedad Española de Neurociencia (2011) Congress
    Salamanca (Talk)
  • 97. Temas candentes en la enfermedad de Pakinson y Trastornos del movimiento. M. Cruz Rodriguez Oroz
    Forum trastornos del movimiento (2011) Congress
    Madrid (Talk)

Other merits and matters

  • Moderator in the Roundtable: “Parkinson’s Disease, motor impairment, and problems related to advanced therapies”. XV Reunión Anual de Vídeos Grupo de Estudio de Trastornos del Movimiento de la SEN. Madrid, 10-11 Abril 2015 (2015)
  • Moderator in the Roundtable: “Parkinson Disease, Parkinsonisms, and problems related to EP advanced therapy”. XIV Reunión Anual de los Vídeos Grupo de Estudio de Trastornos del Movimiento de la SEN. Madrid, 4-5 Abril 2014. (2014)
  • Moderator in the Roundtable: “Evolution and Challenges in Parkinson’s Disease”. Lundbeck Scientific Meeting. Sitges, 25-26 April 2014 (2014)
  • Moderator of the Workshops. Lundbeck Scientific Meeting. Sitges, 25-26 April 2014 (2014)
  • Reviewer of the scientific communications presented during the LXVI Reunión Anual Sociedad Española de Neurología, 18-22 November 2014. (2014)
  • Beca concedida a Manuel Delgado. Titulo: Biomarcadores de deterioro cognitivo leve en enfermedad de Parkinson Importe: 10.000 euros Duración: 1 año Entidad financiadora: Fundación Jsús de Gangoiti Barrera (2013)
 
Release performed by ecmware
We use cookies of our own and of third parties to improve our services and to be able to offer you, by means of web browsing analysis, the best options.
If you continue browsing, we assume that you agree to their use. For further information, please click here.